Sentences with phrase «rare pharmacogenomic»

It also alludes to the complex phenotypes and rare drug outcomes resulting from rare pharmacogenomic variants.

Not exact matches

Themed «Rare Genomics: Genomics of Rare Diseases, Rare Cancers and rare Drug Outcomes», this international scientific event will revolve around the application of the most important disciplines of Genomic Medicine, such as Genome discovery, informatics, Public Health, and drug design in Rare Diseases, Cancer and PharmacogenomRare Genomics: Genomics of Rare Diseases, Rare Cancers and rare Drug Outcomes», this international scientific event will revolve around the application of the most important disciplines of Genomic Medicine, such as Genome discovery, informatics, Public Health, and drug design in Rare Diseases, Cancer and PharmacogenomRare Diseases, Rare Cancers and rare Drug Outcomes», this international scientific event will revolve around the application of the most important disciplines of Genomic Medicine, such as Genome discovery, informatics, Public Health, and drug design in Rare Diseases, Cancer and PharmacogenomRare Cancers and rare Drug Outcomes», this international scientific event will revolve around the application of the most important disciplines of Genomic Medicine, such as Genome discovery, informatics, Public Health, and drug design in Rare Diseases, Cancer and Pharmacogenomrare Drug Outcomes», this international scientific event will revolve around the application of the most important disciplines of Genomic Medicine, such as Genome discovery, informatics, Public Health, and drug design in Rare Diseases, Cancer and PharmacogenomRare Diseases, Cancer and Pharmacogenomics.

The Genomic Medicine Alliance activities are divided into 8 Working Groups, namely Genome Informatics, Pharmacogenomics, Cancer Genomics, Rare Diseases, Public Health Genomics, Economic evaluation in Genomic Medicine, Genethics, and Quality Assurance.

The 1st session included lectures related to clinical implementation of Pharmacogenomics, featuring the keynote lecture by Prof. Julie Johnson (University of Florida, Tampa, FL, USA), followed by Prof. Markus Paulmichl (Paracelsus University, Salzburg, Austria), who provided an overview of the implementation of Pharmacogenomics in Austria and Prof. Magnus Ingelman - Sundberg (Karolinska Institutet, Stockholm, Sweden), who talked about sequencing of rare variants of pharmacogePharmacogenomics, featuring the keynote lecture by Prof. Julie Johnson (University of Florida, Tampa, FL, USA), followed by Prof. Markus Paulmichl (Paracelsus University, Salzburg, Austria), who provided an overview of the implementation of Pharmacogenomics in Austria and Prof. Magnus Ingelman - Sundberg (Karolinska Institutet, Stockholm, Sweden), who talked about sequencing of rare variants of pharmacogePharmacogenomics in Austria and Prof. Magnus Ingelman - Sundberg (Karolinska Institutet, Stockholm, Sweden), who talked about sequencing of rare variants of pharmacogenomicspharmacogenomics interest.